Clinical Trial Update: An Open Label Pilot Study of IV Brexanolone for the Treatment of Post-Traumatic Stress Disorder [Phase 4]

View source ↗

Summary

An open-label Phase 4 pilot study is evaluating intravenous brexanolone for post-traumatic stress disorder, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Zulresso (brexanolone)

Snippet

Sponsor: Donald Jeffrey Newport | Conditions: Post-Traumatic Stress Disorder | Phase 4 | Status: RECRUITING